Overview

Balloon Aortic Valvuloplasty Performed Without Heparin to Decrease Vascular and Bleeding Complications of the Procedure

Status:
Terminated
Trial end date:
2016-10-22
Target enrollment:
Participant gender:
Summary
To assess if the non use of heparin sodium during balloon aortic valvuloplasty reduces serious complications due to the procedure, by decreasing the rate of vascular and hemorrhagic complications without increasing the rate of ischeamic events.
Phase:
Phase 4
Details
Lead Sponsor:
University Hospital, Montpellier
Treatments:
Calcium heparin
Heparin